This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,552.00, was awarded by the Defense Logistics Agency (DLA) on December 11, 2024 as a firm fixed-price delivery order. The contract covers the delivery of MIRENA 52 MG SYSTEMS, with a period of performance through January 3, 2025. This contract is not associated with any set-aside designation. As a key supplier to the Department of Defense (DoD), DMS Pharmaceutical Group has a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.
Generated 3/12/25, 10:03 AM